IGC Pharma IGC
NYSE IGC
$0.28 +0.01 (+3.70%)
At close: Oct 2, 2026 · 4:00 PM EDT

IGC Pharma (IGC) Gains from Sales and Divestitures (2022 - 2025)

Updated

IGC Pharma (IGC) reported Gains from Sales and Divestitures of $11,000 for Q4 2025, up 450.0% from $2,000 a year earlier.

Analysis

IGC Pharma (IGC) Gains from Sales and Divestitures (2022 - 2025) Analysis & Trends

For FY2025, IGC Pharma posted Gains from Sales and Divestitures of $25,000, down 43.2% from FY2024.

  • By year, Gains from Sales and Divestitures came in at $44,000 in FY2024 and -$39,000 in FY2023.
  • The Q4 2025 figure ranks as the highest quarterly Gains from Sales and Divestitures since Q2 2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn
10 IGC Pharma 27.66 Mn 24.91 Mn 55,000.00
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2025 11,000.00
Mar 31, 2024 2,000.00
Dec 31, 2022 6,000.00
Sep 30, 2022 23,000.00
Jun 30, 2022 -68,000.00
API Access

IGC Pharma Gains from Sales and Divestitures API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gains-from-sales-and-divestitures&ticker=IGC&period=max&api_key=YOUR_API_KEY